Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 1, 2010, Pages 39-44

  Ceccarelli, Antonia ^a   Rocca, Maria A ^a   Neema, Mohit ^b   Martinelli, Vittorio ^a   Arora, Ashish ^b   Tauhid, Shahamat ^b   Ghezzi, Angelo ^c   Comi, Giancarlo ^a   Bakshi, Rohit ^b   Filippi, Massimo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Ospedale di Gallarate   (Italy)

Author keywords

Caudate nucleus; Clinically isolated syndromes; Gray matter T2 hypointensity; Iron deposition; Magnetic resonance imaging

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; IRON STORAGE; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PUTAMEN; THALAMUS;

ADULT; ANALYSIS OF VARIANCE; BASAL GANGLIA; BRAIN; CAUDATE NUCLEUS; DISABILITY EVALUATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; NERVE DEGENERATION; THALAMUS;

EID: 73949143323     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509350310     Document Type: Article

References (52)

1. Pirko I., Lucchinetti CF, Sriram S., Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007 ; 68: 634-642.
2. Ceccarelli A., Rocca MA, Pagani E., et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. NeuroImage 2008 ; 42: 315-322.
3. Charil A., Filippi M. Inflammatory demyelination and neurodegeneration in early multiple sclerosis. J Neurol Sci 2007 ; 259: 7-15.
4. Yu CS, Lin FC, Liu Y., Duan Y., Lei H., Li KC Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008 ; 68: 328-334.
5. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004 ; 127: 1101-1107.
6. Iannucci G., Tortorella C., Rovaris M., Sormani MP, Comi G., Filippi M. Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. AJNR Am J Neuroradiol 2000 ; 21: 1034-1038.
7. Filippi M., Iannucci G., Tortorella C., et al. Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 1999 ; 52: 588-594. (Pubitemid 29075609)
8. Kapeller P., Brex PA, Chard D., et al. Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002 ; 8: 207-210.
9. Yu CS, Lin FC, Liu Y., Duan Y., Lei H., Li KC Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008 ; 68: 328-334.
10. Anderson VM, Fernando KT, Davies GR, et al. Cerebral atrophy measurement in clinically isolated syndromes and relapsing remitting multiple sclerosis: a comparison of registration-based methods. J Neuroimaging 2007 ; 17: 61-68.
11. Khalil M., Enzinger C., Langkammer C., et al. Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler 2009 ; 15: 1048-1054.
12. Ranjeva JP, Audoin B., Au Duong MV, et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. AJNR Am J Neuroradiol 2005 ; 26: 119-127, (Erratum in: AJNR Am J Neuroradiol 2005 ; 26: 986 ).
13. Fernando KT, Tozer DJ, Miszkiel KA, et al. Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 2005 ; 128: 2911-2925.
14. Fooladi M., Alam NR, Harirchyan MH, et al. Prognostic value of brain tissue pathological changes in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis using magnetization transfer ratio (MTR). Conf Proc IEEE Eng Med Biol Soc 2007 ; 2007: 2031-2033.
15. Gallo A., Rovaris M., Benedetti B., et al. A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis. J Neurol 2007 ; 254: 78-83.
16. Rocca MA, Agosta F., Sormani MP, et al. A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol 2008 ; 255: 683-691.
17. Gallo A., Rovaris M., Riva R., et al. Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol 2005 ; 62: 803-808.
18. Van Au Duong M., Audoin B., et al. Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS: a MRSI study. J Neurol 2007 ; 254: 914-923.
19. Henry RG, Shieh M., Okuda DT, Evangelista A., Gorno-Tempini ML, Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. J Neurol Neurosurg Psychiatry 2008 ; 79: 1236-1244.
20. Calabrese M., Atzori M., Bernardi V., et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007 ; 254: 1212-1220.
21. Fisher E., Lee JC, Nakamura K., Rudick RA Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008 ; 64: 255-265.
22. Fisniku LK, Chard DT, Jackson JS, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008 ; 64: 247-254. (Erratum in: Ann Neurol 2009 ; 65: 232 ).
23. Rovaris M., Judica E., Ceccarelli A., et al. A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol 2008 ; 255: 1209-1214.
24. Brass SD, Benedict RH, Weinstock-Guttman B., Munschauer F., Bakshi R. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis. Mult Scler 2006 ; 12: 437-444.
25. Houtchens MK, Benedict RH, Killiany R., et al. Thalamic atrophy and cognition in multiple sclerosis. Neurology 2007 ; 69: 1213-1223.
26. Bakshi R., Miletich RS, Kinkel PR, Emmer ML, Kinkel WR High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging 1998 ; 8: 228-234.
27. Brownell B., Hughes JT The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962 ; 25: 315-320.
28. Bermel RA, Innus MD, Tjoa CW, Bakshi R. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. NeuroReport 2003 ; 14: 335-339.
29. Geurts JJ, Reuling IE, Vrenken H., et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006 ; 55: 478-483.
30. Ciccarelli O., Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001 ; 56: 926-933.
31. Fabiano AJ, Sharma J., Weinstock-Guttman B., et al. Thalamic involvement in multiple sclerosis: a diffusion weighted magnetic resonance imaging study. J Neuroimaging 2003 ; 13: 307-314.
32. Bakshi R., Shaikh ZA, Janardhan V. MRI T2 shortening (black T2) in multiple sclerosis: frequency, location, and clinical correlation. Neuroreport 2000 ; 11: 15-21.
33. Bakshi R., Benedict RH, Bermel RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002 ; 59: 62-68.
34. Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B., et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005 ; 62: 1371-1376.
35. Neema M., Arora A., Healy B., et al. Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis. J Neuroimaging 2009 ; 19: 3-8.
36. Tjoa CW, Benedict RH, Weinstock-Guttman B., Fabiano AJ, Bakshi R. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005 ; 234: 17-24.
37. Zhang Y., Zabad RK, Wei X., Metz LM, Hill MD, Mitchell JR Deep grey matter blackT2 on 3 tesla magnetic resonance imaging correlates with disability in multiple sclerosis. Mult Scler 2007 ; 13: 880-883.
38. Ceccarelli A., Filippi M., Neema M., et al. T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis. Mult Scler 2009 ; 15: 678-686.
39. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 ; 33: 1444-1452.
40. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 ; 13: 227-231.
41. McDonald WI, Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
42. Stankiewicz J., Panter SS, Neema M., Arora A., Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007 ; 4: 371-386.
43. Hasan KM, Halphen C., Kamali A., Nelson FM, Wolinsky JS, Narayana PA Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding gray matter degeneration. J Magn Reson Imaging 2009 ; 29: 70-77.
44. Bermel RA, Bakshi R., Tjoa C., Puli SR, Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002 ; 59: 275-280.
45. Caon C., Zvartau-Hind M., Ching W., Lisak RP, Tselis AC, Khan OA Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis. Neurology 2003 ; 60: 323-325.
46. Roelcke U., Kappos L., Lechner-Scott J., et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997 ; 48: 1566-1571.
47. Mesaros S., Rovaris M., Pagani E., et al. An MRI voxel based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Arch Neurol 2008 ; 65: 1223-1230.
48. Prinster A., Quarantelli M., Orefice G., et al. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel based morphometry study. NeuroImage 2006 ; 29: 859-867.
49. Fabiano AJ, Horsfield MA, Bakshi R. Interhemispheric asymmetry of brain diffusivity in normal individuals: a diffusion-weighted MR imaging study. AJNR Am J Neuroradiol 2005 ; 26: 1089-1094.
50. Traboulsee A., Dehmeshki J., Brex PA, et al. Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS. Neurology 2002 ; 59: 126-128.
51. Hammond KE, Metcalf M., Carvajal L., et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol 2008 ; 64: 707-713.
52. Ge Y., Jensen JH, Lu H., et al. Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging. AJNR Am J Neuroradiol 2007 ; 28: 1639-1644.